Sonendo, Inc. (NYSE:SONX – Get Free Report) Director Olav Bergheim purchased 75,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 16th. The shares were bought at an average price of $0.26 per share, with a total value of $19,500.00. Following the completion of the acquisition, the director now owns 1,171,373 shares of the company’s stock, valued at approximately $304,556.98. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Sonendo Price Performance
NYSE SONX opened at $0.25 on Friday. The company has a quick ratio of 5.80, a current ratio of 6.83 and a debt-to-equity ratio of 0.98. The stock has a market capitalization of $13.57 million, a PE ratio of -0.38 and a beta of 2.04. The company has a 50 day moving average price of $0.46 and a two-hundred day moving average price of $0.94. Sonendo, Inc. has a 12-month low of $0.21 and a 12-month high of $2.95.
Institutional Trading of Sonendo
Institutional investors have recently added to or reduced their stakes in the business. Renaissance Technologies LLC acquired a new stake in Sonendo in the fourth quarter valued at approximately $30,000. HighTower Advisors LLC acquired a new stake in Sonendo in the fourth quarter valued at approximately $31,000. XTX Topco Ltd acquired a new stake in Sonendo in the first quarter valued at approximately $39,000. Bank of New York Mellon Corp acquired a new stake in Sonendo in the first quarter valued at approximately $41,000. Finally, Bank of America Corp DE lifted its stake in Sonendo by 210.6% in the first quarter. Bank of America Corp DE now owns 16,618 shares of the company’s stock valued at $66,000 after acquiring an additional 11,267 shares during the last quarter. 59.92% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Sonendo Company Profile
Sonendo, Inc, a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure.
- Five stocks we like better than Sonendo
- Basic Materials Stocks Investing
- S&P 500’s Whirlwind: Big gains, warning whispers & tactical moves
- Which Wall Street Analysts are the Most Accurate?
- MarketBeat Week in Review – 11/13 – 11/17
- How to Invest in Casino Stocks
- 3 large caps with red hot RSIs with upside
Receive News & Ratings for Sonendo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonendo and related companies with MarketBeat.com's FREE daily email newsletter.